產(chǎn)品基本信息
產(chǎn)品編號：D300000
產(chǎn)品名稱：DHA-Paclitaxel
產(chǎn)品CAS：199796-52-6
規(guī)格含量：5mg
產(chǎn)品價格：面議
聯(lián)系我們:
產(chǎn)品詳細(xì)介紹
標(biāo)準(zhǔn)品編號:
D300000
名稱:
DHVIP(LA)Paclitaxel
別名:
Paclitaxel 2'-(all-cis-4,7,10,13,16,19-docosahexaenoate); Taxoprexin; (αR,βS)-β-(Benzoylamino)-α-[[(4Z,7Z,10Z,13Z,16Z,19Z)-1-oxo-4,7,10,13,16,19-docosahexaenyl]oxy]-Benzenepropanoic Acid Mono[(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl] Ester; [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-β-(Benzoylamino)-α-[(1-oxo-4,7,10,13,16,19-docosahexaenyl)oxy]benzenepropanoic Acid, 6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester;
CAS號:
199796-52-6
分子式:
C??H??NO??
分子量:
1164.38
種類:
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
DHVIP(LA)Paclitaxel is a fatty acid derivative of Paclitaxel (P132500), an antineoplastic. Used in the study of structure and function of microtubles into tubulin. Paclitaxel is now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi's sarcoma.
參考文獻(xiàn)
Letourneau, P.C., et al.: J. Cell Biol., 98, 1355 (1984), Manfredi, J.J., et al.: Pharmacol. Ther., 25, 83 (1984), Danesi, R., et al.: Mol. Pharmacol., 47, 1106 (1995), Markman, M., et al.: Expert. Opin. Pharmacother., 3, 755 (2002), Stone, G.W., et al.: N. Engl. J. Med., 350, 221 (2004),
?您的位置：
